✦ LIBER ✦

Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5mg–10mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects

✍ Scribed by Silke Retlich, Vincent Duval, Arne Ring, Alexander Staab, Silke Hüttner, Arvid Jungnik, Ulrich Jaehde, Klaus A. Dugi, Dr Ulrike Graefe-Mody

Book ID: 119930904
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 279 KB
Volume: 49
Category: Article
ISSN: 0312-5963
DOI: 10.2165/11536620-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers

✍ Hüttner, S.; Graefe-Mody, E. U.; Withopf, B.; Ring, A.; Dugi, K. A. 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 217 KB

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

✍ Ronald Christopher; Paul Covington; Michael Davenport; Penny Fleck; Qais A. Mekk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Linagliptin, a dipeptidyl peptidase-4 in

Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects

✍ Akiko Sarashina; Shogo Sesoko; Mitsuyoshi Nakashima; Naoyuki Hayashi; Atsushi Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB